The story of Sildenafil offers a complex case study for analysts eyeing pharma. While early sales were astounding, present patent expiration and the rise of generic versions have considerably influenced earnings. https://murrayiipo114966.bcbloggers.com/39845186/sildenafil-and-pharma-a-risky-stake